Dr. van der Linden and Ms Feitsma contributed equally to this work.
Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis
Article first published online: 30 JUL 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 60, Issue 8, pages 2242–2247, August 2009
How to Cite
van der Linden, M. P. M., Feitsma, A. L., le Cessie, S., Kern, M., Olsson, L. M., Raychaudhuri, S., Begovich, A. B., Chang, M., Catanese, J. J., Kurreeman, F. A. S., van Nies, J., van der Heijde, D. M., Gregersen, P. K., Huizinga, T. W. J., Toes, R. E. M. and van der Helm-Van Mil, A. H. M. (2009), Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis & Rheumatism, 60: 2242–2247. doi: 10.1002/art.24721
- Issue published online: 30 JUL 2009
- Article first published online: 30 JUL 2009
- Manuscript Accepted: 8 MAY 2009
- Manuscript Received: 3 FEB 2009
- NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institute of Allergy and Infectious Diseases). Grant Numbers: N01-AR-2-2263, R01-AR-44422
- Dutch Arthritis Foundation
- European Commission Seventh Framework Programme (projects Masterswitch and AutoCure)
- Centre for Medical Systems Biology
- The Netherlands Organization for Health Research and Development
The severity of joint destruction in rheumatoid arthritis (RA) is highly variable from patient to patient and is influenced by genetic factors. Genome-wide association studies have enormously boosted the field of the genetics of RA susceptibility, but risk loci for RA severity remain poorly defined. A recent meta-analysis of genome-wide association studies identified 6 genetic regions for susceptibility to autoantibody-positive RA: CD40, KIF5A/PIP4K2C, CDK6, CCL21, PRKCQ, and MMEL1/TNFRSF14. The purpose of this study was to investigate whether these newly described genetic regions are associated with the rate of joint destruction.
RA patients enrolled in the Leiden Early Arthritis Clinic were studied (n = 563). Yearly radiographs were scored using the Sharp/van der Heijde method (median followup 5 years; maximum followup 9 years). The rate of joint destruction between genotype groups was compared using a linear mixed model, correcting for age, sex, and treatment strategies. A total of 393 anti–citrullinated protein antibody (ACPA)–positive RA patients from the North American Rheumatoid Arthritis Consortium (NARAC) who had radiographic data available were used for the replication study.
The TT and CC/CG genotypes of 2 single-nucleotide polymorphisms, rs4810485 (CD40) and rs42041 (CDK6), respectively, were associated with a higher rate of joint destruction in ACPA-positive RA patients (P = 0.003 and P = 0.012, respectively), with rs4810485 being significant after Bonferroni correction for multiple testing. The association of the CD40 minor allele with the rate of radiographic progression was replicated in the NARAC cohort (P = 0.021).
A polymorphism in the CD40 locus is associated with the rate of joint destruction in patients with ACPA-positive RA. Our findings provide one of the first non–HLA-related genetic severity factors that has been replicated.